GL1X · GenesisL1 explorer

Research workbench

Structure of sybody MR17 in complex with the SARS-cov-2 S receptor- binding domain (rbd)

Analyse Structure of sybody MR17 in complex with the SARS-cov-2 S receptor- binding… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7C8W
Type
protein
Length
315 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P0DTC2
Ligands
NAG, FUC

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein120——
B—protein195—P0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains B
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7C8W · Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.